The University of Chicago Header Logo

Connection

Shilpa Keerthivasan to Carcinoma, Transitional Cell

Back to Details
This is a "connection" page, showing publications Shilpa Keerthivasan has written about Carcinoma, Transitional Cell.
Shilpa Keerthivasan
Connection Strength
0.041
Carcinoma, Transitional Cell
  1. High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nat Med. 2020 05; 26(5):693-698.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.